People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular self-expanding valve saw similar clinical outcomes and superior valve performance at one year compared with those who underwent TAVR with a balloon-expandable valve, according to research presented at the American College of Cardiology’s Annual Scientific Session.
Partnered with Lilly, TVM Capital and Tillotts fund oral inflammatory bowel disease drug with up to $28M
Mage Biologics debuted Thursday with a $28 million commitment from TVM Capital Life Science and specialty pharma company Tillotts Pharma. The new biotech is centered